The only four medications approved by the US Food and Drug Administration for AD are acetylcholinesterase (AChE) inhibitors (donepezil, galantamine, and rivastigmine) and NMDA antagonists (memantine) (Cummings et al. 2022). Here, ACHE is linked to Alzheimer disease.